-transparent.png){kind=logo}
The relationship between nuclear glutathione levels and resistance to melphalan in human ovarian tumour cells. 1991
CRC Dept Radiation Oncology, University of Liverpool, J. K. Douglas Laboratories, Clatterbridge Hospital, Bebington, Wirral, U.K.
Related Publications
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
December 1992,
Melanoma research,
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
October 1988,
Cancer research,
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
October 1995,
Cell biology and toxicology,
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
December 1986,
Molecular pharmacology,
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
August 1991,
British journal of cancer,
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
August 1996,
British journal of cancer,
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
July 1990,
The British journal of radiology,
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
January 2019,
Cancer drug resistance (Alhambra, Calif.),
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
November 1984,
Cancer research,
R A Britten, and
J A Green, and
C Broughton, and
P G Browning, and
R White, and
H M Warenius
January 1981,
Cancer treatment reports,
